Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21465394 | 1.00 | L3MBTL1 (0.44) | L3MBTL1TNFCYP1A2SMN1; SMN2CYP2D6 | |
| SCHEMBL2452044 | 0.80 | ABCB11 (0.61) | L3MBTL1CYP1A2LMNAALOX5 | |
| SCHEMBL2452047 | 0.80 | ABCB11 (0.61) | L3MBTL1CYP1A2LMNAALOX5 | |
| SCHEMBL28958757 | 0.74 | CYP1A2 (0.68) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| SCHEMBL4589554 | 0.74 | CYP1A2 (0.68) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| SCHEMBL528282 | 0.74 | KMT2A (0.43) | L3MBTL1TNFCYP1A2KMT2AALDH1A1 | |
| SCHEMBL4590669 | 0.74 | CYP1A2 (0.68) | CYP1A2SMN1; SMN2CYP2D6PKMNPSR1 | |
| SCHEMBL5497954 | 0.72 | ALDH1A1 (0.39) | TNFKMT2AALDH1A1POLBMTNR1A | |
| SCHEMBL5497959 | 0.72 | ALDH1A1 (0.39) | PKMKMT2AALDH1A1POLBMTNR1A | |
| SCHEMBL14861206 | 0.72 | L3MBTL1 (0.61) | L3MBTL1CYP1A2SMN1; SMN2CYP2D6PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 426 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107431-A1 | STEREOSELECTIVE SYNTHESIS OF L,2-CIS-2-AMINOGLYCOSIDES | BRANDEIS UNIVERSITY (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4734976-A2 | AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS | RyCarma Therapeutics, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026090589-A1 | HETEROCYCLIC HBS1L DEGRADERS | TANGO THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4688758-A1 | VERDAZYL COMPOUNDS AS CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING OF KIDNEYS | Yellowbird Diagnostics Inc. (CA) | 2026-02-11 | — | — | EP | disclosed |
| EP-4658280-A2 | SIX MEMBERED RING CONTAINING OLIGOMERS | Alnylam Pharmaceuticals, Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| EP-4543990-A1 | INDOCYANINE GREEN (ICG) MODIFICATION FOR TREATMENT OF LIVER CANCER | The Children's Medical Center Corporation (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2025006617-A2 | AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS | ARMGO PHARMA, INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024220852-A2 | TEAD CORE INHIBITORS FOR CANCER THERAPEUTICS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-10-24 | — | — | WO | disclosed |
| EP-4444274-A1 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | The Children's Medical Center Corporation (US) | 2024-10-16 | — | — | EP | disclosed |
| EP-4440560-A1 | SMALL MOLECULE INHIBITORS OF REPEAT ASSOCIATED NON-AUG (RAN) TRANSLATION AND COMBINATION THERAPIES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-10-09 | — | — | EP | disclosed |
| WO-2009020768-A1 | TARGETING THE ONCOPROTEIN NUCLEOPHOSMIN | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-02-12 | — | — | WO | disclosed |
| WO-2009018088-A2 | IMAGING OF ALPHA-SYNUCLEIN | LINK MEDICINE CORPORATION (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008137692-A1 | TREATMENT OF SYNUCLEINOPATHIES | LINK MEDICINE CORPORATION (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008127361-A2 | SYNTHESIS OF ENONE INTERMEDIATE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2008-10-23 | — | — | WO | disclosed |
| WO-2008121767-A2 | STITCHED POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008122038-A1 | REGULATING AUTOPHAGY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008119015-A2 | SYNTHESIS OF THIOHYDANTOINS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008063300-A2 | BORONIC ACIDS AND ESTERS AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE | INFINITY PHARMACEUTICALS, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
| EP-0970066-A1 | AMINOEPOXIDES FROM AMINOALDEHYDES AND IN-SITU FORMED HALOMETHYL ORGANOMETALLIC REAGENT | G.D. SEARLE & CO. (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998029401-A1 | AMINOEPOXIDES FROM AMINOALDEHYDES AND IN-SITU FORMED HALOMETHYL ORGANOMETALLIC REAGENT | G.D. SEARLE & CO. (US) | 1998-07-09 | — | — | WO | disclosed |